This invention discloses the application of the TRIM58
gene in regulating host resistance to
Mycobacterium bovis infection. A bovine
macrophage cell line with TRIM58
gene knockout was constructed using
CRISPR / Cas9 technology. Results showed that TRIM58 knockout significantly inhibited
intracellular survival of
Mycobacterium bovis and reduced infection-induced
cell death; reintroduction or overexpression of TRIM58 restored or enhanced bacterial viability. Therefore, this invention is the first to demonstrate that TRIM58 is a
negative regulator of host resistance to
Mycobacterium bovis infection, and that inhibitors of the TRIM58
gene can be used to prepare drugs against
Mycobacterium bovis infection or to treat
bovine tuberculosis. This invention fills a research gap in the field of TRIM58 in
bovine tuberculosis and provides an effective tool for screening and studying the mechanisms of action of anti-
bovine tuberculosis drugs.